Proteomics International Laboratories (ASX:PIQ) Other Net Income (Loss) : A$0.11 Mil (TTM As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories Other Net Income (Loss)?

Proteomics International Laboratories's Other Net Income (Loss) for the six months ended in Jun. 2024 was A$0.11 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 was A$0.11 Mil.

Proteomics International Laboratories's quarterly Other Net Income (Loss) stayed the same from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$0.00 Mil) but then increased from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.11 Mil).

Proteomics International Laboratories Other Net Income (Loss) Historical Data

The historical data trend for Proteomics International Laboratories's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories Other Net Income (Loss) Chart

Proteomics International Laboratories Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Net Income (Loss)

Get a 7-Day Free Trial

Proteomics International Laboratories Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Net Income (Loss)	Get a 7-Day Free Trial														-	-	-	-	0.11

Proteomics International Laboratories Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.11 Mil.

Proteomics International Laboratories Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Proteomics International Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009

Website

https://www.proteomics.com.au

Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories Headlines

No Headlines